scholarly article | Q13442814 |
P50 | author | Carla V. Rothlin | Q41071298 |
Lionel B Ivashkiv | Q58297759 | ||
P2093 | author name string | Drazen Sosic | |
Eric N. Olson | |||
Greg Lemke | |||
Erin Kelly | |||
M. Nusrat Sharif | |||
P2860 | cites work | Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7 | Q24533409 |
Twist2, a novel ADD1/SREBP1c interacting protein, represses the transcriptional activity of ADD1/SREBP1c | Q24633793 | ||
The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist | Q24644315 | ||
A twist code determines the onset of osteoblast differentiation | Q28510533 | ||
Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family | Q28585446 | ||
twist is required in head mesenchyme for cranial neural tube morphogenesis | Q28590860 | ||
IgG Fc receptors | Q29615378 | ||
Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction | Q29620054 | ||
Toll-like receptor 9-induced type I IFN protects mice from experimental colitis | Q33683729 | ||
Phagocytosis and clearance of apoptotic cells is mediated by MER. | Q33946282 | ||
Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy | Q33973488 | ||
A weak signal for strong responses: interferon-alpha/beta revisited | Q34238056 | ||
Interferons alpha and beta as immune regulators--a new look | Q34289965 | ||
The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases | Q34319294 | ||
Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences | Q34387889 | ||
Novel mechanism for gonadotropin-releasing hormone neuronal migration involving Gas6/Ark signaling to p38 mitogen-activated protein kinase | Q34440186 | ||
Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells | Q34529299 | ||
Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback | Q34532725 | ||
Interferon-alpha as an immunotherapeutic protein. | Q34584092 | ||
Macrophage regulation by Tyro 3 family receptors | Q35031954 | ||
Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study | Q35595986 | ||
Type I interferon modulation of cellular responses to cytokines and infectious pathogens: potential role in SLE pathogenesis | Q35675517 | ||
Autoimmunity through cytokine-induced dendritic cell activation | Q35772872 | ||
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta | Q35894501 | ||
Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes | Q36399578 | ||
Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. | Q36399581 | ||
Type I interferon production enhances susceptibility to Listeria monocytogenes infection | Q36399599 | ||
IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. | Q40460766 | ||
Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers | Q40632310 | ||
Gas6 anti-apoptotic signaling requires NF-kappa B activation. | Q40796453 | ||
Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist | Q41192770 | ||
Cross talk of the interferon-alpha/beta signalling complex with gp130 for effective interleukin-6 signalling | Q43688291 | ||
Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis | Q43873069 | ||
Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study | Q45099936 | ||
Interferon-alpha prevents endotoxin-induced mortality in mice | Q45217481 | ||
Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy | Q45855775 | ||
Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity | Q47614351 | ||
IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. | Q52550265 | ||
A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. | Q54102022 | ||
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β | Q57675150 | ||
Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. | Q64917731 | ||
IFN-alpha suppresses activation of nuclear transcription factors NF-kappa B and activator protein 1 and potentiates TNF-induced apoptosis | Q73112892 | ||
Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains | Q73943058 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammation | Q101991 |
Twist basic helix-loop-helix transcription factor 1 | Q14906441 | ||
Twist basic helix-loop-helix transcription factor 2 | Q21980164 | ||
AXL receptor tyrosine kinase | Q21991362 | ||
P304 | page(s) | 1891–1901 | |
P577 | publication date | 2006-08-07 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | Twist mediates suppression of inflammation by type I IFNs and Axl | |
P478 | volume | 203 |
Q40117278 | A critical role of Gas6/Axl signal in allergic airway responses during RSV vaccine-enhanced disease |
Q22001524 | A possible inflammatory role of twist1 in human white adipocytes |
Q38042615 | A tale with a Twist: a developmental gene with potential relevance for metabolic dysfunction and inflammation in adipose tissue |
Q36127308 | AXL is an essential factor and therapeutic target for metastatic ovarian cancer |
Q26863442 | AXL kinase as a novel target for cancer therapy |
Q37684598 | AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer |
Q61807743 | Anti-Inflammatory Role of TAM Family of Receptor Tyrosine Kinases Via Modulating Macrophage Function |
Q47354821 | Apoptotic Cells Induced Signaling for Immune Homeostasis in Macrophages and Dendritic Cells |
Q38409398 | Autophagy induced by AXL receptor tyrosine kinase alleviates acute liver injury via inhibition of NLRP3 inflammasome activation in mice |
Q36851881 | Autoregulation of Th1-mediated inflammation by twist1. |
Q39820482 | Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis |
Q35872028 | Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma |
Q36720080 | Axl-dependent signalling: a clinical update |
Q37258717 | Biology of the TAM receptors |
Q30490447 | CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions |
Q28393487 | Carbon nanotube-induced pulmonary granulomatous disease: Twist1 and alveolar macrophage M1 activation |
Q37690725 | Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity |
Q41612823 | Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy |
Q51029121 | Deletion of the receptor tyrosine kinase Tyro3 inhibits synovial hyperplasia and bone damage in arthritis. |
Q33941433 | Dendritic cells in systemic lupus erythematosus |
Q90090969 | Depletion of ID3 enhances mesenchymal stem cells therapy by targeting BMP4 in Sjögren's syndrome |
Q91659317 | Does Axl have potential as a therapeutic target in pancreatic cancer? |
Q60950078 | Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics |
Q39123271 | Efferocytosis Signaling in the Regulation of Macrophage Inflammatory Responses |
Q34652571 | Efferocytosis and lung disease |
Q91855383 | Efferocytosis in health and disease |
Q37118186 | Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines |
Q44877361 | Epigenetic regulation of AXL and risk of childhood asthma symptoms |
Q37762478 | Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer |
Q41552614 | Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer |
Q47240053 | Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage |
Q81007695 | Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis |
Q37352392 | Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination. |
Q54301060 | Gas6'ing the innate immune response during experimental asthma. |
Q28571857 | Gene expression profiling of pulmonary fibrosis identifies Twist1 as an antiapoptotic molecular "rectifier" of growth factor signaling |
Q38772267 | Giving AXL the axe: targeting AXL in human malignancy |
Q37325341 | Growth arrest-specific protein 6 attenuates neutrophil migration and acute lung injury in sepsis |
Q34163837 | Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury. |
Q53264081 | HDAC9, TWIST1 and FERD3L gene expression in asymptomatic stable and unstable carotid plaques. |
Q37541225 | Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE. |
Q35757367 | Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response |
Q47148088 | Human Metapneumovirus Attachment Protein Contributes to Neutrophil Recruitment into the Airways of Infected Mice. |
Q36494607 | IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice |
Q36340889 | Identification of Axl as a downstream effector of TGF-β1 during Langerhans cell differentiation and epidermal homeostasis |
Q33796991 | Immunobiology of the TAM receptors |
Q33999355 | In brain, Axl recruits Grb2 and the p85 regulatory subunit of PI3 kinase; in vitro mutagenesis defines the requisite binding sites for downstream Akt activation |
Q37048321 | Increased cAMP in monocytes augments Notch signaling mechanisms by elevating RBP-J and transducin-like enhancer of Split (TLE) |
Q33765614 | Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy. |
Q35018856 | Inhibition of caveolin-1 restores myeloid cell function in human glioblastoma |
Q60954877 | Innate Immune Cell Suppression and the Link With Secondary Lung Bacterial Pneumonia |
Q35803259 | LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFα expression and receptor tyrosine kinase signaling |
Q37089521 | Liver X receptor and STAT1 cooperate downstream of Gas6/Mer to induce anti-inflammatory arginase 2 expression in macrophages |
Q35063750 | Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitis |
Q26795638 | Macrophage adaptation in airway inflammatory resolution |
Q52653114 | Macrophage-Derived Protein S Facilitates Apoptotic Polymorphonuclear Cell Clearance by Resolution Phase Macrophages and Supports Their Reprogramming. |
Q36446918 | MerTK is required for apoptotic cell-induced T cell tolerance |
Q41985907 | Modulation of inflammasome-mediated pulmonary immune activation by type I IFNs protects bone marrow homeostasis during systemic responses to Pneumocystis lung infection |
Q37034582 | Molecular mechanisms of the anti-inflammatory functions of interferons |
Q38076049 | Negative regulation of human mononuclear phagocyte function |
Q26824524 | Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms |
Q21195364 | Overview of the biology of type I interferons |
Q58616776 | PD-1 immunobiology in systemic lupus erythematosus |
Q28588141 | Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer |
Q36222919 | Prostaglandin E₂ induces oncostatin M expression in human chronic wound macrophages through Axl receptor tyrosine kinase pathway |
Q34609215 | Redundant or separate entities?--roles of Twist1 and Twist2 as molecular switches during gene transcription |
Q38969143 | Regulation of p21 by TWIST2 contributes to its tumor-suppressor function in human acute myeloid leukemia |
Q39097028 | Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection |
Q95856210 | Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders |
Q37735773 | Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS. |
Q33756349 | Role of growth arrest-specific gene 6 in the development of fungal allergic airway disease in mice |
Q64235512 | Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis |
Q42151105 | Specific inactivation of Twist1 in the mandibular arch neural crest cells affects the development of the ramus and reveals interactions with hand2. |
Q24321466 | Survival and migration of human dendritic cells are regulated by an IFN-alpha-inducible Axl/Gas6 pathway |
Q34804259 | Systemic autoimmunity in TAM triple knockout mice causes inflammatory brain damage and cell death |
Q35553941 | TAM receptor deficiency affects adult hippocampal neurogenesis |
Q37804572 | TAM receptor signaling and autoimmune disease |
Q35819380 | TAM receptor signaling in immune homeostasis |
Q34794927 | TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer |
Q37408769 | TAM receptors affect adult brain neurogenesis by negative regulation of microglial cell activation |
Q38105573 | TAM receptors in apoptotic cell clearance, autoimmunity, and cancer |
Q24297562 | TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages |
Q34365639 | TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis |
Q34545399 | TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling |
Q37728859 | TWISTing an embryonic transcription factor into an oncoprotein |
Q91712029 | Targeting ADAM10 in Cancer and Autoimmunity |
Q35602267 | The Axl receptor tyrosine kinase is a discriminator of macrophage function in the inflamed lung. |
Q57470611 | The Dual Role of TAM Receptors in Autoimmune Diseases and Cancer: An Overview |
Q28067131 | The Gas6/TAM System and Multiple Sclerosis |
Q27928010 | The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy |
Q36161704 | The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells |
Q37341028 | The cancer cell--leukocyte fusion theory of metastasis |
Q26822434 | The emerging role of Twist proteins in hematopoietic cells and hematological malignancies |
Q42326768 | The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment |
Q24299966 | The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry |
Q39382358 | The unique immunological and microbial aspects of pregnancy |
Q35771028 | Twist1 Is a TNF-Inducible Inhibitor of Clock Mediated Activation of Period Genes. |
Q41500221 | Twist1 and Twist2 Contribute to Cytokine Downregulation following Chronic NOD2 Stimulation of Human Macrophages through the Coordinated Regulation of Transcriptional Repressors and Activators |
Q41954129 | Twist1 regulates Ifng expression in Th1 cells by interfering with Runx3 function. |
Q36071793 | Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection |
Q37808291 | Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance. |
Q83790490 | Type I IFN protects against antigen-induced arthritis |
Q40372633 | Type I IFNs Act upon Hematopoietic Progenitors To Protect and Maintain Hematopoiesis during Pneumocystis Lung Infection in Mice |
Q35879429 | Type I Interferon Induced Epigenetic Regulation of Macrophages Suppresses Innate and Adaptive Immunity in Acute Respiratory Viral Infection |
Q38293686 | Type I Interferon Regulates the Placental Inflammatory Response to Bacteria and is Targeted by Virus: Mechanism of Polymicrobial Infection-Induced Preterm Birth. |
Q47927601 | Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation |
Q34314664 | Tyro3 receptor tyrosine kinases in the heterogeneity of apoptotic cell uptake |
Q37257176 | Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions |
Q43869657 | Upregulation of PSCDBP, TLR2, TWIST1, FLJ35382, EDNRB, and RGS12 gene expression in human myometrium at labor. |
Q37122103 | Vitamin K-dependent actions of Gas6. |
Q64083065 | p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts |